These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 31662526)

  • 1. Outcome of Oral and Intra-arterial Nimodipine Administration After Aneurysmal Subarachnoid Haemorrhage - A Single-centre Study.
    Ehrlich G; Kirschning T; Wenz H; Hegewald AA; Neumaier-Probst E; Seiz-Rosenhagen M
    In Vivo; 2019; 33(6):1967-1975. PubMed ID: 31662526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is intra arterial nimodipine really beneficial in vasospasm following aneurysmal subarachnoid haemorrhage?
    Goel R; Aggarwal A; Salunke P; Kumar A; Chhabra R
    Br J Neurosurg; 2016 Aug; 30(4):407-10. PubMed ID: 26999260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of nimodipine monotherapy and combined treatment with ketamine and lignocaine in aneurysmal subarachnoid haemorrhage.
    Langelaar G; Leeuwenkamp OR; Sterkman LG; Torreman M; Hesselink JM
    J Int Med Res; 1996; 24(5):425-32. PubMed ID: 8895046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous selective intra-arterial application of nimodipine in refractory cerebral vasospasm due to aneurysmal subarachnoid hemorrhage.
    Ott S; Jedlicka S; Wolf S; Peter M; Pudenz C; Merker P; Schürer L; Lumenta CB
    Biomed Res Int; 2014; 2014():970741. PubMed ID: 24527461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nimodipine after aneurysmal subarachnoid hemorrhage: Fourteen-day course for patients that meet criteria for early hospital discharge.
    Sokolowski JD; Chen CJ; Soldozy S; Mastorakos P; Burke RM; Nguyen JM; Myers KM; Kalani MYS; Park MS
    Clin Neurol Neurosurg; 2021 Jan; 200():106299. PubMed ID: 33092929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of 14 Versus 21 Days of Nimodipine Therapy on Neurological Outcomes in Aneurysmal Subarachnoid Hemorrhage Patients.
    Cho S; Bales J; Tran TK; Korab G; Khandelwal N; Joffe AM
    Ann Pharmacother; 2016 Sep; 50(9):718-24. PubMed ID: 27273676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous intra-arterial nimodipine infusion in patients with severe refractory cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a feasibility study and outcome results.
    Bele S; Proescholdt MA; Hochreiter A; Schuierer G; Scheitzach J; Wendl C; Kieninger M; Schneiker A; Bründl E; Schödel P; Schebesch KM; Brawanski A
    Acta Neurochir (Wien); 2015 Dec; 157(12):2041-50. PubMed ID: 26439105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-arterial nimodipine infusion for cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage.
    Cho WS; Kang HS; Kim JE; Kwon OK; Oh CW; Son YJ; Know BJ; Jung C; Hang MH
    Interv Neuroradiol; 2011 Jun; 17(2):169-78. PubMed ID: 21696654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poor Utilization of Nimodipine in Aneurysmal Subarachnoid Hemorrhage.
    Hajizadeh Barfejani A; Rabinstein AA; Wijdicks EFM; Clark SL
    J Stroke Cerebrovasc Dis; 2019 Aug; 28(8):2155-2158. PubMed ID: 31103551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of Arterial Hypotension in Patients Receiving Peroral or Continuous Intra-arterial Nimodipine After Aneurysmal or Perimesencephalic Subarachnoid Hemorrhage.
    Kieninger M; Gruber M; Knott I; Dettmer K; Oefner PJ; Bele S; Wendl C; Tuemmler S; Graf B; Eissnert C
    Neurocrit Care; 2019 Aug; 31(1):32-39. PubMed ID: 30725331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Course and Monitoring Parameters After Continuous Interventional Intra-Arterial Treatment in Patients with Refractory Cerebral Vasospasm.
    von der Brelie C; Doukas A; Stopfer A; Larsen N; Mehdorn M; Synowitz M; Jansen O
    World Neurosurg; 2017 Apr; 100():504-513. PubMed ID: 28131927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Early Versus Late Intravenous Followed by Oral Nimodipine Treatment on the Occurrence of Delayed Cerebral Ischemia Among Patients With Aneurysm Subarachnoid Hemorrhage.
    Samseethong T; Suansanae T; Veerasarn K; Liengudom A; Suthisisang C
    Ann Pharmacother; 2018 Nov; 52(11):1061-1069. PubMed ID: 29783859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-arterial nimodipine for severe cerebral vasospasm after aneurysmal subarachnoid hemorrhage: influence on clinical course and cerebral perfusion.
    Hänggi D; Turowski B; Beseoglu K; Yong M; Steiger HJ
    AJNR Am J Neuroradiol; 2008 Jun; 29(6):1053-60. PubMed ID: 18372422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra-arterial nimodipine for cerebral vasospasm after subarachnoid haemorrhage: Influence on clinical course and predictors of clinical outcome.
    Bashir A; Andresen M; Bartek J; Cortsen M; Eskesen V; Wagner A
    Neuroradiol J; 2016 Feb; 29(1):72-81. PubMed ID: 26825134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
    Schmid-Elsaesser R; Kunz M; Zausinger S; Prueckner S; Briegel J; Steiger HJ
    Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term, Continuous Intra-Arterial Nimodipine Treatment of Severe Vasospasm After Aneurysmal Subarachnoid Hemorrhage.
    Hockel K; Diedler J; Steiner J; Birkenhauer U; Danz S; Ernemann U; Schuhmann MU
    World Neurosurg; 2016 Apr; 88():104-112. PubMed ID: 26732964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
    Ehlert A; Schmidt C; Wölfer J; Manthei G; Jacobs AH; Brüning R; Heindel W; Ringelstein EB; Stummer W; Pluta RM; Hesselmann V
    J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nimodipine Dose Reductions in the Treatment of Patients with Aneurysmal Subarachnoid Hemorrhage.
    Sandow N; Diesing D; Sarrafzadeh A; Vajkoczy P; Wolf S
    Neurocrit Care; 2016 Aug; 25(1):29-39. PubMed ID: 26690937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Intra-Arterial and Intravenous Nimodipine Therapy of Cerebral Vasospasm After Subarachnoid Hemorrhage on Cerebrovascular Reactivity and Oxygenation.
    Hockel K; Diedler J; Steiner J; Birkenhauer U; Ernemann U; Schuhmann MU
    World Neurosurg; 2017 May; 101():372-378. PubMed ID: 28232152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Trial Protocol: Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy, and Safety Study Comparing EG-1962 to Standard of Care Oral Nimodipine in Adults with Aneurysmal Subarachnoid Hemorrhage [NEWTON-2 (Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After SubarachNoid Hemorrhage)].
    Hänggi D; Etminan N; Mayer SA; Aldrich EF; Diringer MN; Schmutzhard E; Faleck HJ; Ng D; Saville BR; Macdonald RL;
    Neurocrit Care; 2019 Feb; 30(1):88-97. PubMed ID: 30014184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.